1177
Patients treated with 5-ASA compounds who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease should be screened to rule out a lupus-like reaction.
 Patients: Subject; who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease: Subject; lupus-like reaction: Effect; 5-ASA compounds: Treatment; 5-ASA: Treatment.Drug; gastrointestinal disease: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Patients: Subject; who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease: Subject; lupus-like reaction: Effect; 5-ASA compounds: Treatment; 5-ASA: Treatment.Drug; gastrointestinal disease: Treatment.Disorder